Sandu Pharmaceuticals has opened a special window from February 5, 2026, to February 4, 2027, for shareholders to re-lodge transfer requests for physical share certificates.

This initiative, following SEBI guidelines, is specifically for requests made before April 1, 2019, that were previously rejected or not processed due to documentation issues.

Importantly, shares re-lodged during this period will only be processed into dematerialized form.

This helps shareholders convert older physical holdings, improving liquidity and ease of management.